PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration

Experimental Eye Research

Volumn 87, Issue 3, 2008, Pages 226-241

  Huang, Qiong ^a   Wang, Shoujian ^a   Sorenson, Christine M ^a   Sheibani, Nader ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

angiogenesis; apoptosis, proliferation; endothelial cells; oxygen induced ischemic retinopathy; pericytes; VEGF

Indexed keywords

OXYGEN; PIGMENT EPITHELIUM DERIVED FACTOR; TRYPSIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION; RETINOPATHY; STAINING;

ANIMALS; APOPTOSIS; ASTROCYTES; CELL PROLIFERATION; EYE PROTEINS; HYPEROXIA; IN SITU NICK-END LABELING; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE GROWTH FACTORS; RETINA; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 50849125085     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.06.003     Document Type: Article

References (42)

1. Amano S., Yamagishi S., Inagaki Y., Nakamura K., Takeuchi M., Inoue H., and Imaizumi T. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes. Microvasc. Res. 69 1-2 (2005) 45-55
2. Becerra S.P. Structure-function studies on PEDF. A noninhibitory serpin with neurotrophic activity. Adv. Exp. Med. Biol. 425 (1997) 223-237
3. Becerra S.P., Sagasti A., Spinella P., and Notario V. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J. Biol. Chem. 270 43 (1995) 25992-25999
4. Behling K.C., Surace E.M., and Bennett J. Pigment epithelium-derived factor expression in the developing mouse eye. Mol. Vis. 8 (2002) 449-454
5. Bhutto I.A., Kim S.Y., McLeod D.S., Merges C., Fukai N., Olsen B.R., and Lutty G.A. Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 45 5 (2004) 1544-1552
6. Bhutto I.A., McLeod D.S., Hasegawa T., Kim S.Y., Merges C., Tong P., and Lutty G.A. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp. Eye Res. 82 1 (2006) 99-110
7. Bouck N. PEDF: anti-angiogenic guardian of ocular function. Trends Mol. Med. 8 7 (2002) 330-334
8. Cao W., Tombran-Tink J., Chen W., Mrazek D., Elias R., and McGinnis J.F. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J. Neurosci. Res. 57 6 (1999) 789-800
9. Chen L., Zhang S.S., Barnstable C.J., and Tombran-Tink J. PEDF induces apoptosis in human endothelial cells by activating p38 MAP kinase dependent cleavage of multiple caspases. Biochem. Biophys. Res. Commun. 348 4 (2006) 1288-1295
10. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H., Benedict W., and Bouck N.P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 285 5425 (1999) 245-248
11. Doll J.A., Stellmach V.M., Bouck N.P., Bergh A.R., Lee C., Abramson L.P., Cornwell M.L., Pins M.R., Borensztajn J., and Crawford S.E. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat. Med. 9 6 (2003) 774-780
12. Eichler W., Yafai Y., Keller T., Wiedemann P., and Reichenbach A. PEDF derived from glial Muller cells: a possible regulator of retinal angiogenesis. Exp. Cell Res. 299 1 (2004) 68-78
13. Emert M.P., Sorenson C.M., Basile D.P., Rogers J.G., Hammerman M.R., and Billadello J.J. The human plasminogen activator inhibitor type I gene promoter targets to kidney. Am. J. Physiol 274 2 Pt 2 (1998) F405-F412
14. Fruttiger M. Development of the retinal vasculature. Angiogenesis 10 2 (2007) 77-88
15. Funatsu H., Yamashita H., Nakamura S., Mimura T., Eguchi S., Noma H., and Hori S. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 113 2 (2006) 294-301
16. Ho T.C., Chen S.L., Yang Y.C., Liao C.L., Cheng H.C., and Tsao Y.P. PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc. Res. 76 2 (2007) 213-223
17. Ito M., and Yoshioka M. Regression of the hyaloid vessels and pupillary membrane of the mouse. Anat. Embryol. 200 4 (1999) 403-411
18. Kanda S., Mochizuki Y., Nakamura T., Miyata Y., Matsuyama T., and Kanetake H. Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn. J. Cell Sci. 118 Pt 5 (2005) 961-970
19. Karakousis P.C., John S.K., Behling K.C., Surace E.M., Smith J.E., Hendrickson A., Tang W.X., Bennett J., and Milam A.H. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol. Vis. 7 (2001) 154-163
20. Mizota A., and Adachi-Usami E. Effect of body temperature on electroretinogram of mice. Invest. Ophthalmol. Vis. Sci. 43 12 (2002) 3754-3757
21. Mori K., Gehlbach P., Yamamoto S., Duh E., Zack D.J., Li Q., Berns K.I., Raisler B.J., Hauswirth W.W., and Campochiaro P.A. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43 6 (2002) 1994-2000
22. Ogata N., Matsuoka M., Matsuyama K., Shima C., Tajika A., Nishiyama T., Wada M., Jo N., Higuchi A., Minamino K., Matsunaga H., Takeda T., and Matsumura M. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. J. Clin. Endocrinol. Metab. 92 3 (2007) 1176-1179
23. Ogata N., Nishikawa M., Nishimura T., Mitsuma Y., and Matsumura M. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am. J. Ophthalmol. 134 3 (2002) 348-353
24. Ohno-Matsui K., Morita I., Tombran-Tink J., Mrazek D., Onodera M., Uetama T., Hayano M., Murota S.I., and Mochizuki M. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.J. Cell Physiol. 189 3 (2001) 323-333
25. Pierce E.A., Avery R.L., Foley E.D., Aiello L.P., and Smith L.E.H. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92 3 (1995) 905-909
26. Scheef E., Wang S., Sorenson C.M., and Sheibani N. Isolation and characterization of murine retinal astrocytes. Mol. Vis. 11 (2005) 613-624
27. Sheibani N., Sorenson C.M., Cornelius L.A., and Frazier W.A. Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia. Biochem. Biophys. Res. Commun. 267 1 (2000) 257-261
28. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., and D'Amore P.A. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35 1 (1994) 101-111
29. Steele F.R., Chader G.J., Johnson L.V., and Tombran-Tink J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl. Acad. Sci. USA. 90 4 (1993) 1526-1530
30. Stellmach V., Crawford S.E., Zhou W., and Bouck N. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc. Natl. Acad. Sci. USA. 98 5 (2001) 2593-2597
31. Suzuma K., Takagi H., Otani A., Oh H., and Honda Y. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. Am. J. Pathol. 154 2 (1999) 343-354
32. Tombran-Tink J., and Barnstable C.J. PEDF: a multifaceted neurotrophic factor. Nat. Rev. Neurosci. 4 8 (2003) 628-636
33. Tombran-Tink J., and Johnson L.V. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest. Ophthalmol. Vis. Sci. 30 8 (1989) 1700-1707
34. Uno K., Bhutto I.A., McLeod D.S., Merges C., and Lutty G.A. Impaired expression of thrombospondin-1 in eyes with age related macular degeneration. Br. J. Ophthalmol. 90 1 (2006) 48-54
35. Valenzuela D.M., Murphy A.J., Frendewey D., Gale N.W., Economides A.N., Auerbach W., Poueymirou W.T., Adams N.C., Rojas J., Yasenchak J., Chernomorsky R., Boucher M., Elsasser A.L., Esau L., Zheng J., Griffiths J.A., Wang X., Su H., Xue Y., Dominguez M.G., Noguera I., Torres R., Macdonald L.E., Stewart A.F., DeChiara T.M., and Yancopoulos G.D. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat. Biotechnol. 21 6 (2003) 652-659
36. Wang S., Wu Z., Sorenson C.M., Lawler J., and Sheibani N. Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration. Dev. Dyn. 228 4 (2003) 630-642
37. Wiegand S.J., Song H., Renard R., Kraus P., Adams N., Gale N.W., Noguera I., Qian Y., Zabski S., Yancopoulos G.D., and Cao J. Genetic modulation of pigment epithelium-derived factor (PEDF) expression does not alter normal or pathological angiogenesis in the eye, or tumor growth. Invest. Ophthalmol. Vis. Sci. 45 (2004) #1884
38. Wong W.T., Rex T.S., Auricchio A., Maguire A.M., Chung D., Tang W., and Bennett J. Effect of over-expression of pigment epithelium derived factor (PEDF) on developing retinal vasculature in the mouse. Mol. Vis. 10 (2004) 837-844
39. Yafai Y., Lange J., Wiedemann P., Reichenbach A., and Eichler W. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions. Glia. 55 6 (2007) 642-651
40. Yamagishi S., Nakamura K., Matsui T., Inagaki Y., Takenaka K., Jinnouchi Y., Yoshida Y., Matsuura T., Narama I., Motomiya Y., Takeuchi M., Inoue H., Yoshimura A., Bucala R., and Imaizumi T. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J. Biol. Chem. 281 29 (2006) 20213-20220
41. Yamagishi S., Nakamura K., Takenaka K., Matsui T., Jinnouchi Y., and Imaizumi T. Pigment epithelium-derived factor (PEDF) promotes growth of pericytes through autocrine production of platelet-derived growth factor-B. Microvasc. Res. 69 3 (2005) 128-134
42. Zhang S.X., Wang J.J., Gao G., Parke K., and Ma J.X. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J. Mol. Endocrinol. 37 1 (2006) 1-12